October 7, 2014—Hospitals groups have responded forcefully to a new study in the journal Health Affairs that its authors say supports the position that disproportionate share hospitals increasingly use 340B savings to help themselves at the expense of the poor. … [Read more...]
OPA to Collect 340B Ceiling-Price Information
Long-awaited move required under ACASeptember 30, 2014 --The Office of Pharmacy Affairs published a notice in today’s Federal Register announcing plans to collect pricing information from manufacturers to help verify the accuracy of 340B ceiling prices, as required by the Affordable Care Act. … [Read more...]
Apexus Awarded HRSA’s Prime Vendor Contract
Group will continue to serve as the 340B Prime Vendor five more yearsSeptember 30, 2014—The Health Resources and Services Administration has awarded a five-year contract to Apexus to continue to run the 340B Prime Vendor Program. … [Read more...]
HHS Looks at ACA’s Early Effect on Hospital Uncompensated Care
Less of a burden expected, mainly in Medicaid expansion statesSeptember 25, 2014—Preliminary data on health care reform's Medicaid and insurance coverage expansions suggest some hospitals' uncompensated care burden will lessen in 2014, the U.S. Department of Health and Human Services reports. … [Read more...]
How 340B Saves Lives on the Gulf Coast
Kudos to Executive Insight staff writer Michael Jones for his moving profile of Shannon Williams, an uninsured Mississippi woman with cancer who received lifesaving charity care from Monroe County Hospital in Monroeville, Ala., made possible by the hospital's participation in 340B. She originally received treatment from the hospital in 2006 when she had health insurance and … [Read more...]
340B Duplicate Discounts a Hot Topic at Drug Industry Conference
Medicaid expansion and move away from fee-for-service toward managed care cited as reasonsSeptember 24, 2014—Medicaid expansion in general and Medicaid managed care growth in particular have drug manufacturers concentrating on 340B duplicate discounts as never before. … [Read more...]
OIG Says Drugmakers’ Coupons May Be Skewing Part D Drug Purchases
Special bulletin reminds companies about potential liability under anti-kickback statuteSeptember 24, 2014—Pharmaceutical manufacturers’ current safeguards may not prevent all copayment coupons from being used for drugs paid for by Medicare Part D, the U.S. Health and Human Services Office of Inspector General says in a new report. … [Read more...]